Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -132,481 | -87,315 | -83,895 | -53,241 | -38,659 |
| Depreciation Amortization | 39,340 | 22,352 | 5,397 | 15,068 | 11,357 |
| Accounts receivable | -26,231 | -19,451 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,243 | 192 | 1,418 | 1,277 | 868 |
| Other Working Capital | 11,252 | -17,200 | -9,666 | 10,062 | 15,369 |
| Other Operating Activity | 117,440 | 98,998 | 78,147 | -322 | -475 |
| Operating Cash Flow | $13,563 | $-2,424 | $-8,599 | $-27,156 | $-11,540 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 147,060 | 147,060 | 132,736 | -151,981 | -132,066 |
| PPE Investments | -32,564 | -23,270 | -14,975 | -95,683 | -80,693 |
| Net Acquisitions | -432,558 | -432,558 | -432,577 | N/A | N/A |
| Sale Of Investment | 6,876 | 3,438 | 3,438 | 7,487 | N/A |
| Purchase Sale Intangibles | 15,655 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 15,655 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-295,531 | $-305,330 | $-311,378 | $-240,177 | $-212,759 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 241,831 | 241,831 | 241,831 | N/A | N/A |
| Debt Repayment | -609 | -392 | -277 | -1,353 | -1,022 |
| Common Stock Issued | 131,117 | 11,587 | 2,105 | 18,313 | 14,453 |
| Financing Cash Flow | $372,339 | $253,026 | $243,659 | $16,960 | $13,431 |
| Beginning Cash Position | 91,395 | 91,395 | 91,395 | 341,768 | 341,768 |
| End Cash Position | 181,766 | 36,667 | 15,077 | 91,395 | 130,900 |
| Net Cash Flow | $90,371 | $-54,728 | $-76,318 | $-250,373 | $-210,868 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,563 | -2,424 | -8,599 | -27,156 | -11,540 |
| Capital Expenditure | -32,564 | -23,270 | -14,975 | -95,683 | -80,693 |
| Free Cash Flow | -19,001 | -25,694 | -23,574 | -122,839 | -92,233 |